The Architect of Post-Acute Care: David Schuppan

David Schuppan

Co-President of Flagship Funds & Co-Head of Healthcare, The Vistria Group

David Schuppan is a primary architect of the modern healthcare investment landscape, currently serving as the Co-President of Flagship Funds and Co-Head of Healthcare at The Vistria Group. With over 25 years of experience, David has led more than $10 billion in healthcare investments across 28 different companies, earning a reputation as a "steward of capital" who prioritizes clinical impact alongside financial performance.

A Career Built on "Connected Intelligence"

A native of central Missouri, David’s path to the top of the private equity world began with a simple desire to support entrepreneurs who reminded him of his father—an "accidental entrepreneur" in his own right. After starting his career in healthcare investment banking at Bear, Stearns & Co. in New York, David moved to Chicago to join Thoma Cressey Equity Partners at its inception.

He later became a Co-Founder and Partner at Cressey & Company, where he was instrumental in the firm’s first major healthcare wins, including being the original investor in Homecare Homebase. In 2017, David joined The Vistria Group, where he helped pioneer the "Next Gen" private equity model that operates strictly at the intersection of purpose and profit.

Transforming the Post-Acute Ecosystem

David is widely recognized for his expertise in in-home care, value-based delivery, and clinical technology. He has been a driving force behind many of the most influential names in the post-acute ecosystem, serving on the boards of:

Technology Leaders: Medalogix (Mosai), Homecare Homebase, and Tango.

Care Providers: Help at Home, VitalCaring, Mission Healthcare, and Sevita.

Specialized Services: Anew Health (formerly HomeFree Pharmacy), Agape Care, and St. Croix Hospice.

His investment philosophy is rooted in "active listening"—finding technology and services that solve real-world friction for caregivers on the front lines. David believes that by improving clinical outcomes for complex and vulnerable populations, strong business returns naturally follow.

Background & Education

David graduated summa cum laude from Indiana University and received his M.B.A. with honors from The Wharton School at the University of Pennsylvania. Beyond the boardroom, he remains a dedicated mentor to the next generation of healthcare leaders and a vocal advocate for shifting the industry focus from "IQ" (data analysis) to "EQ" (human-to-human care).

Despite his global reach, David remains a "student of the game," maintaining the same Missouri-bred hustle and curiosity that defined his early days in the industry.

All resources